A US Food and Drug Administration perspective on evaluating medical products for Ebola.

A US Food and Drug Administration perspective on evaluating medical products for Ebola. Clin Trials. 2016 Jan 14; Authors: Russek-Cohen E, Rubin D, Price D, Sun W, Cox E, Borio L PMID: 26768565 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26768565?dopt=Abstract

Source: Clinical Trials - January 14, 2016 Category: Research Authors: Russek-Cohen E, Rubin D, Price D, Sun W, Cox E, Borio L Tags: Clin Trials Source Type: research

More News: Clinical Trials | Ebola | Food and Drug Administration (FDA) | Research